Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

NCT01043393 ·Status: COMPLETED ·Phase: PHASE2

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

NCT02985736 ·Status: COMPLETED ·Phase: PHASE4

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

NCT01206660 ·Status: COMPLETED ·Phase: PHASE3

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

NCT02340169 ·Status: COMPLETED ·Phase: PHASE4

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

NCT01206387 ·Status: COMPLETED ·Phase: PHASE3

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

NCT01018134 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis

NCT02749656 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

NCT05896527 ·Status: COMPLETED ·Phase: PHASE2

Sulodexide in Controlling the Recurrence of Psoriasis

NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Moderate to Severe Plaque Psoriasis With Scalp Involvement

NCT00791765 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

NCT00236119 ·Status: COMPLETED ·Phase: PHASE2

Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

NCT01936337 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

NCT03880357 ·Status: COMPLETED ·Phase: PHASE1

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris

NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

NCT01368887 ·Status: SUSPENDED ·Phase: PHASE2

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

NCT00005660 ·Status: COMPLETED

A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

NCT00601107 ·Status: COMPLETED ·Phase: PHASE2

Study of a New Dressing for Use With Topical Medications

NCT00234728 ·Status: COMPLETED ·Phase: NA

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

NCT04566666 ·Status: COMPLETED ·Phase: PHASE2

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

NCT03004339 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

NCT06308393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

NCT03331523 ·Status: COMPLETED ·Phase: PHASE3

Daxxin Psoriasis Shampoo PMCF

NCT06771648 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp

NCT05105139 ·Status: COMPLETED

Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression

NCT01698333 ·Status: COMPLETED ·Phase: PHASE2